SCHEMBL7257346

SCHEMBL7257346

CC1(C)CCCC(C(=O)OCC(=O)O)O1

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17541903 0.76 MAPK1 (0.34) CYP1A2
SCHEMBL27861743 0.74 L3MBTL1 (0.32)
SCHEMBL19565571 0.73 LMNA (0.40)
SCHEMBL27917374 0.66 UGT2B7 (0.38) CYP1A2
SCHEMBL8003858 0.64 MAPK1 (0.35)
SCHEMBL6201777 0.64 ATM (0.46)
SCHEMBL8003854 0.64 MAPK1 (0.35)
SCHEMBL2625619 0.63 ALDH1A1 (0.46)
SCHEMBL737022 0.61
SCHEMBL19747687 0.60 MAPK1 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1328527-A1 CEPHALOTAXANES, THEIR METHOD OF PREPARATION AND THEIR USE IN TREATMENT OF CANCERS, LEUKEMIAS, PARASITES INCLUDING THOSE RESISTANT TO USUAL CHEMOTHERAPEUTIC AGENTS AND AS REVERSAL AGENTS Oncopharm Corporation (US) 2003-07-23 EP disclosed
WO-2002032904-A1 NEW CEPHALOTAXANES, THEIR METHOD OF PREPARATION AND THEIR USE IN TREATMENT OF CANCERS, LEUKEMIAS, PARASITES INCLUDING THUS RESISTANT TO USUAL CHEMOTHERAPEUTIC AGENTS AND AS REVERSAL AGENTS ONCOPHARM CORPORATION (FR) 2002-04-25 WO disclosed